Zhe Jiang Dayang Biotech Group Co., Ltd. (SHE:003017)
China · Delayed Price · Currency is CNY 33.09
+0.56 (1.72%)
At close: Feb 13, 2026
SHE:003017 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 92.52 | 63.75 | 50.01 | 80.73 | 70.01 | 91.61 |
Depreciation & Amortization | 68.32 | 68.32 | 69.67 | 60.25 | 45.1 | 31.3 |
Other Amortization | 0.6 | 0.6 | 0.05 | 0.05 | 0.05 | 0.05 |
Loss (Gain) From Sale of Assets | -0.09 | -0.09 | 0.17 | -3.41 | -0.12 | 0 |
Asset Writedown & Restructuring Costs | 7.98 | 7.98 | 17.02 | 0.19 | 1.89 | 1.8 |
Loss (Gain) From Sale of Investments | -2.2 | -2.2 | -3.21 | -4.62 | -11.28 | -1.64 |
Provision & Write-off of Bad Debts | 1.08 | 1.08 | -1.58 | 1.77 | 0.18 | 0.53 |
Other Operating Activities | 41.06 | 9.6 | 9.17 | 6.49 | 3.95 | 1.33 |
Change in Accounts Receivable | -94.51 | -94.51 | 5.99 | -65.96 | -40.69 | -94.86 |
Change in Inventory | 30.2 | 30.2 | -28.27 | 34.56 | -93.26 | 12.49 |
Change in Accounts Payable | -30.75 | -30.75 | 59.87 | -6.8 | -16.73 | 68.09 |
Change in Other Net Operating Assets | 4.46 | 4.46 | 7.27 | 11.95 | - | - |
Operating Cash Flow | 126.43 | 66.19 | 182.42 | 91.89 | -35.16 | 112.49 |
Operating Cash Flow Growth | -23.50% | -63.71% | 98.53% | - | - | -0.53% |
Capital Expenditures | -62.68 | -63.45 | -103.63 | -104.65 | -93.43 | -124.82 |
Sale of Property, Plant & Equipment | -0.83 | 0.94 | 1.36 | 6.85 | 0.72 | 0.31 |
Investment in Securities | 47 | -106 | 241.9 | -20.48 | 89.35 | -369 |
Other Investing Activities | 1.53 | 1.2 | 5.45 | 8.4 | 12.25 | 0.53 |
Investing Cash Flow | -14.98 | -167.3 | 145.08 | -109.88 | 8.89 | -492.98 |
Long-Term Debt Issued | - | 715.86 | 519.38 | 556.51 | 138.66 | 54.87 |
Total Debt Issued | 726.89 | 715.86 | 519.38 | 556.51 | 138.66 | 54.87 |
Long-Term Debt Repaid | - | -599.44 | -552.45 | -454.84 | -10.96 | -28 |
Total Debt Repaid | -706.44 | -599.44 | -552.45 | -454.84 | -10.96 | -28 |
Net Debt Issued (Repaid) | 20.44 | 116.42 | -33.07 | 101.67 | 127.7 | 26.87 |
Issuance of Common Stock | 35.85 | 35.85 | - | 42.36 | - | 432.75 |
Repurchase of Common Stock | -41.96 | -41.96 | - | -88.1 | - | - |
Common Dividends Paid | -25.83 | -42.71 | -42.61 | -39.06 | -38.31 | -14.07 |
Dividends Paid | -25.83 | -42.71 | -42.61 | -39.06 | -38.31 | -14.07 |
Other Financing Activities | 28.47 | -1.04 | - | - | - | -49.18 |
Financing Cash Flow | 16.98 | 66.56 | -75.68 | 16.87 | 89.4 | 396.37 |
Foreign Exchange Rate Adjustments | 0.49 | 0.27 | -0.1 | -0.96 | -0 | -0.24 |
Net Cash Flow | 128.91 | -34.28 | 251.73 | -2.09 | 63.13 | 15.64 |
Free Cash Flow | 63.74 | 2.74 | 78.8 | -12.76 | -128.59 | -12.33 |
Free Cash Flow Growth | -8.74% | -96.52% | - | - | - | - |
Free Cash Flow Margin | 6.47% | 0.30% | 8.57% | -1.21% | -16.42% | -1.82% |
Free Cash Flow Per Share | 0.79 | 0.03 | 0.98 | -0.16 | -1.53 | -0.19 |
Cash Income Tax Paid | 20.74 | 24.47 | 31.05 | 0.12 | 11.65 | 10.59 |
Levered Free Cash Flow | 130.72 | -14.49 | 71.45 | 44.17 | -103.2 | 13.39 |
Unlevered Free Cash Flow | 133.52 | -10.26 | 75.29 | 47.59 | -101.47 | 13.8 |
Change in Working Capital | -82.85 | -82.85 | 41.12 | -49.56 | -144.93 | -12.49 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.